06 June 2019

Appointment of Non-Executive Director

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces the appointment of Wade Rosen to the Company's Board as a Non-Executive Director with immediate effect.

Mr Rosen joins the board following the completion of the strategic investment in the Company by Rosen's Diversified, Inc. (RDI) pursuant to which it was agreed that RDI would be entitled to nominate a non-executive director.  Mr Rosen is a successful business leader, entrepreneur, and co-founder of two business-to-business technology companies, ThrivePass Inc. ("ThrivePass") and Wishlist Rewards LLC ("Wishlist").  Mr Rosen currently serves as a Director of RDI, and as Executive Vice President at Scientific Life Solutions, a subsidiary of RDI. He also serves as a Director for Wishlist and Flagship Biosciences, Inc. and as Chairman of the Board at ThrivePass. Mr. Rosen holds a Bachelor of Business Administration (BBA) in Information Technology & E-Commerce from The University of Denver, and a Masters of Business Administration (MBA) from the Instituto de Empresa in Spain.

David Evans, Chairman of Collagen Solutions, said: "We are delighted to welcome Wade to the Board. Wade arrives at a pivotal time for the Company and we are confident that his appointment will bring immediate value to the Board." 

Pursuant to Schedule 2 (g) of the AIM Rules for Companies, Wade John Rosen (aged 34) has held the following directorships or partnerships in the past five years:

Current Previous
Wellness by Wishlist Inc (doing business as ThrivePass Inc.)
Wishlist Rewards LLC
Flagship Biosciences Inc.
Rosen's Diversified Inc.  
Connect First Inc.

 

Mr Rosen does not currently directly hold any shares in the Company but is a director and shareholder of RDI, which holds 83,600,000 Ordinary Shares.

There is no further information required to be disclosed in respect of the above appointment pursuant to Rule 17 and Schedule 2 (g) of the AIM Rules for Companies.

 

Enquiries:

Collagen Solutions Plc Via Walbrook
Jamal Rushdy, CEO  
Hilary Spence, CFO  
   
Cenkos Securities Plc (Nominated Adviser and Broker) Tel: 0207 397 8900
Giles Balleny (Corporate Finance)  
Max Gould  
   
Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com
Anna Dunphy Mob: 07876 741 001